🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

Based on the social media company, the service has taken down problematic content and prohibited associated keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, glowing reviews and step-by-step guides for preparing or injecting at home.

Within moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Information and Costs

Inside these communities, posts display dark colored packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant medical dangers”.